cerium has been researched along with Acute Respiratory Distress Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allawzi, A; Azeltine, M; Dewberry, LC; Elajaili, H; Hilton, SA; Hu, J; Liechty, KW; Louiselle, AE; Mattson, C; Niemiec, SM; Nozik-Grayck, E; Sakthivel, TS; Sea, S; Singh, S; Smith, B; Wallbank, A; Xu, J; Zgheib, C | 1 |
| Barret, JP; Crisol, FJ; Gomez, P; Gonzalez-Dorrego, M; Solano, I | 1 |
2 other study(ies) available for cerium and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
Cerium oxide nanoparticle delivery of microRNA-146a for local treatment of acute lung injury.
Topics: Animals; Bleomycin; Cerium; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Delivery Systems; Male; Mice; MicroRNAs; Respiratory Distress Syndrome; SARS-CoV-2 | 2021 |
Epidemiology and mortality of adult burns in Catalonia.
Topics: Abbreviated Injury Scale; Adult; Age Factors; Anti-Infective Agents, Local; Body Surface Area; Burns; Burns, Inhalation; Catchment Area, Health; Cerium; Comorbidity; Debridement; Female; Hospitals, General; Humans; Incidence; Male; Middle Aged; Outcome Assessment, Health Care; Patient Admission; Prognosis; Respiratory Distress Syndrome; Spain; Sulfadiazine; Survival Rate; Time Factors | 1999 |